Seasonality Snapshot

Alnylam Pharmaceuticals (ALNY)

Biotech · US · US Healthcare & Biotech
✓ VERIFIED · 15YR REAL DATA
JanFebMarAprMayJunJulAugSepOctNovDec
SEASONAL TAILWIND — July
Strongest Month
July
+10.02% avg · 69% win rate
Weakest Month
October
-4.23% avg · 47% win rate
MonthAvg ReturnWin Rate
January +5.32% 56%
February +0.66% 44%
March -1.40% 44%
April -2.79% 31%
May +5.33% 69%
June +7.88% 69%
July NOW +10.02% 69%
August +7.20% 73%
September +0.83% 47%
October -4.23% 47%
November +8.65% 80%
December -1.52% 40%
These figures are computed from 15 years of actual monthly closing prices. Past seasonal patterns are not a guarantee of future performance. See our methodology for how this is calculated, or visit the Academy to learn how to read seasonal data responsibly.

Alnylam Pharmaceuticals seasonality — common questions

What is Alnylam Pharmaceuticals's best month historically?
Historically, July has been Alnylam Pharmaceuticals's strongest month, averaging +10.02% with a 69% win rate over 15 years of data. October has been the weakest at -4.23%.
Is Alnylam Pharmaceuticals seasonal?
Alnylam Pharmaceuticals shows a measurable seasonal pattern: its best and worst months differ by 14.25 percentage points on average. These figures come from 15 years of real monthly closing prices. Seasonality is a historical tendency, not a prediction.
How does Alnylam Pharmaceuticals historically perform in July?
Alnylam Pharmaceuticals is currently in July, which has historically averaged +10.02% with a 69% win rate. That has historically been a seasonally favourable window.

Get the full analysis

Backtest this seasonal pattern, compare it against other assets, set alerts, and explore detrended & presidential-cycle views.

Open the Analyzer →
TimingAX is an independently operated service, not a registered investment adviser. This page is for informational purposes only and is not financial advice.